BostonGene named Leading Innovator in AI-Driven Drug Repurposing

Recognition Highlights Dedication to Innovation and the Transformative Impact of AI-driven Solutions to Advance Drug Development BostonGene, a leading provider of AI-driven, molecular and immune profiling solutions, today announced that it has been named a leading innovator in AI drug repurposing in a recent report published in Pharmaceutical Technology, part...

The post BostonGene named Leading Innovator in AI-Driven Drug Repurposing first appeared on AI-TechPark.

advance dedication development drug development highlights impact innovation machine learning part pharmaceutical profiling provider recognition report solutions technology